Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
Mikimasa Tanada, Minoru Tamiya, Atsushi Matsuo, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 30, pp. 16610-16620
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Cyclic Peptides for Drug Development
Xinjian Ji, Alexander L. Nielsen, Christian Heinis
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 136
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
Atsushi Ohta, Mikimasa Tanada, Shojiro Shinohara, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 44, pp. 24035-24051
Closed Access | Times Cited: 41
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor
Xiaoshen Ma, David L. Sloman, Ruchia Duggal, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 13, pp. 11024-11052
Closed Access | Times Cited: 11
Cysteine‐Specific Multifaceted Bioconjugation of Peptides and Proteins Using 5‐Substituted 1,2,3‐Triazines
Quan Zuo, Yiping Li, Xuanliang Lai, et al.
Advanced Science (2024) Vol. 11, Iss. 21
Open Access | Times Cited: 9
Targeting KRAS Diversity: Covalent Modulation of G12X and Beyond in Cancer Therapy
Tonia Kirschner, Matthias Müller, Daniel Rauh
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6044-6051
Closed Access | Times Cited: 9
Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells
Andrew T. Ball, Soran Mohammed, Cyrielle Doigneaux, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 13, pp. 8877-8886
Open Access | Times Cited: 8
Engineering tRNAs for the Ribosomal Translation of Non-proteinogenic Monomers
Maxwell Sigal, Satomi Matsumoto, Adam T. Beattie, et al.
Chemical Reviews (2024) Vol. 124, Iss. 10, pp. 6444-6500
Closed Access | Times Cited: 8
The coming of age of cyclic peptide drugs: an update on discovery technologies
S You, Glen J Mcintyre, Toby Passioura
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 961-973
Closed Access | Times Cited: 8
Targeting RAF dimers in RAS mutant tumors: From biology to clinic
Huanhuan Yin, Qiulin Tang, Hongwei Xia, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1895-1923
Open Access | Times Cited: 6
Crafting Unnatural Peptide Macrocycles via Rh(III)-Catalyzed Carboamidation
Christopher W. Lamartina, Cassandra A. Chartier, Jillian M. Hirano, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 30, pp. 20868-20877
Closed Access | Times Cited: 5
Membrane Permeability in a Large Macrocyclic Peptide Driven by a Saddle-Shaped Conformation
Justin H. Faris, Emel Adaligil, Nataliya Popovych, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 7, pp. 4582-4591
Open Access | Times Cited: 5
Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation
Alexander L. Nielsen, Zsolt Bognár, Mothukuri Ganesh Kumar, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 26
Open Access | Times Cited: 5
Inhibition of GTPase KRAS G12D : a review of patent literature
Yuhang Li, Le Yang, Xiaoran Li, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 701-721
Closed Access | Times Cited: 4
Comprehensive review of extraction, purification, structural characteristics, pharmacological activities, structure-activity relationship and application of seabuckthorn protein and peptides
Guo Chun-qiu, Ling Na, Haiyan Tian, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139447-139447
Closed Access
Late-stage installation and functionalization of alkyl pyridiniums: a general HTE amenable strategy to access diverse aryl alanine containing macrocyclic peptides
Ahmet Kekec, Lauren My-Linh Tran, Christopher W. Plummer, et al.
Chemical Science (2025)
Open Access
Discovery of INCB159020, an Orally Bioavailable KRAS G12D Inhibitor
Qinda Ye, Artem Shvartsbart, Zhenwu Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy
Laura D'Alessio‐Sands, Joshua Gaynier, Victoria Michel‐Milian, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Macrocyclic peptides as a new class of targeted protein degraders
Xiangyi Jing, Joel P. Mackay, Toby Passioura
RSC Chemical Biology (2025) Vol. 6, Iss. 3, pp. 326-337
Open Access
Scoring Conformational Metastability of Macrocyclic Peptides with Binding Pose Metadynamics
Ryan Dykstra, Dan Sindhikara
Journal of Chemical Information and Modeling (2025)
Closed Access
Triazination/IEDDA Cascade Modular Strategy Installing Pyridines/Pyrimidines onto Tyrosine Enables Peptide Screening and Optimization
Quan Zuo, Xinyi Song, Jie Yan, et al.
Journal of the American Chemical Society (2025)
Closed Access
From lead to market: chemical approaches to transform peptides into therapeutics
Caitlin L. Gare, Andrew M. White, Lara R. Malins
Trends in Biochemical Sciences (2025)
Closed Access
Bridging machine learning and peptide design for cancer treatment: a comprehensive review
Khosro Rezaee, Hossein Eslami
Artificial Intelligence Review (2025) Vol. 58, Iss. 5
Open Access
Preparation of sterically hindered peptides using trifluoroacetyl protection: incorporation of N-alkyl-α,α-dialkyl amino acids into N-alkyl amino acids
Kenichi Nomura, Hidekazu Hochido, Yuya Morita, et al.
Chemical Communications (2025) Vol. 61, Iss. 25, pp. 4856-4859
Closed Access
A Novel Regulator of NLRP3 Inflammasome: Peptides
Zhuo Zuo, Ya Xing Wang, Yanwei Fang, et al.
Peptides (2025) Vol. 187, pp. 171381-171381
Closed Access
Post-synthetic Chemical Functionalization of Peptides
Stephanie A. Barros, Rosaura Padilla‐Salinas, Irini Abdiaj
Elsevier eBooks (2025)
Closed Access
Page 1 - Next Page

Scroll to top